investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Genetic Mechanisms of Survivorship Disparities after Unrelated HCT
Effie W Petersdorf
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Effie W Petersdorf
Fred Hutchinson Cancer Research Center
Seattle, United States
Related projects
Christopher S Carlson
Impact of primary tumor development stage on prognosis and outcome in B-ALL
Leukaemia
Pediatric oncology or childhood cancer
Aude Chapuis
Targeting Leukemia with Memory CD8+ T cells Transduced to Express High-Affinity W
Leukaemia
Martha Lassiter
Duke University Nursing Oncology Training Exchange with Tata Memorial Hospital
Leukaemia
Timothy Jensen Henrich
Impact of Chemotherapy and Stem Cell Transplant on HIV-1 Reservoir Dynamics
Leukaemia
Hematology and hematologic malignancies
Pier Paolo Pandolfi
Targeting Tumor Suppressive Pathways for Cancer Therapy
Leukaemia
Peter D Cole
Markers of Cognitive Decline During Treatment for Childhood ALL
Leukaemia
Stanley R. Riddell
Targeted therapy of B cell malignances with CAR-T cells of defined composition
Leukaemia
Catherine Ju-Ying Wu
(PQD1) lmpact of cytotoxic and targeted therapy on clonal evolution of CLL
Leukaemia
A. Thomas Look
Discovery of New Targets and Pathways for T-ALL Therapy
Leukaemia